Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tecogen (TGEN) EBT (2016 - 2025)

Tecogen's EBT history spans 14 years, with the latest figure at -$4.0 million for Q4 2025.

  • For Q4 2025, EBT fell 238.9% year-over-year to -$4.0 million; the TTM value through Dec 2025 reached -$8.2 million, down 76.92%, while the annual FY2025 figure was -$8.2 million, 76.92% down from the prior year.
  • EBT reached -$4.0 million in Q4 2025 per TGEN's latest filing, down from -$2.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.8 million in Q1 2021 to a low of -$4.0 million in Q4 2025.
  • Average EBT over 5 years is -$799572.6, with a median of -$863632.5 recorded in 2022.
  • Peak YoY movement for EBT: soared 803.54% in 2021, then tumbled 2262.31% in 2022.
  • A 5-year view of EBT shows it stood at $66124.0 in 2021, then crashed by 2262.31% to -$1.4 million in 2022, then decreased by 27.88% to -$1.8 million in 2023, then surged by 35.5% to -$1.2 million in 2024, then crashed by 238.9% to -$4.0 million in 2025.
  • Per Business Quant, the three most recent readings for TGEN's EBT are -$4.0 million (Q4 2025), -$2.1 million (Q3 2025), and -$1.5 million (Q2 2025).